Archive - September 2024
Revolutionizing Pharma Logistics: Integrating Innovation and Efficiency in Supply Chains
Lilly’s EBGLYSS Offers New First-Line Biologic Treatment for Atopic Dermatitis Following FDA Approval
Navigating a Material Supplier Change
Formulating Inhaled Medicines
EMA Recommends Mpox Vaccine for Adolescents
Ori Biotech, Charles River Cell Therapy Manufacturing Platform Collaboration Yields Promising Results
Lonza and Vertex Enter Commercial Supply Agreement for CASGEVY, the Sickle Cell Disease Gene-Edited Cell Therapy
Hatch-Waxman Amendments Turn 40